Saturday 30 April 2022

RIDD trial results have been published.

We have major news! The results of the RIDD trial have been published, and the trial was succesful. The nodules that were injected got softer, and progression stopped. This is major, it means a better understanding of the disease and maybe this injection (adalimumab) can become a treatment for early Dupuytren's in the (near?) future. To see the results: A short video to explain the trial: https://youtu.be/jyoUkLiUg4Q The press release is here: https://www.ndorms.ox.ac.uk/news/breakthrough-in-treatment-for-dupuytren2019s-disease The RIDD page with updated links and information: https://www.ndorms.ox.ac.uk/research/clinical-trials/completed-trials/ridd And the complete article (open access) can be found here: https://www.thelancet.com/journals/lanrhe/article/PIIS2665-9913(22)00093-5/fulltext Read, enjoy, and the community of worldwide researchers and hand surgeons are already starting to comment and discuss this.
Prof Nanchahal as 'TopGun'. credit for the picture to farcanal on ST

No comments:

Post a Comment